financetom
Business
financetom
/
Business
/
FTC probes whether Ticketmaster does enough to stop resale bots, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FTC probes whether Ticketmaster does enough to stop resale bots, Bloomberg News reports
Sep 15, 2025 6:28 PM

(Reuters) -The U.S. Federal Trade Commission is investigating whether Live Nation's Ticketmaster is doing enough to prevent bots from illegally reselling tickets on its platform, Bloomberg News reported on Monday.

The probe, which examines the ticket-selling unit's compliance with the Better Online Ticket Sales (BOTS) Act, is at an advanced stage and a decision on whether to pursue a case could come within weeks, Bloomberg said, citing people familiar with the matter.

The 2016 law prohibits the use of bots and other methods to bypass ticket purchase limits set by online sellers.

As part of the probe, FTC investigators are assessing whether Ticketmaster has a financial incentive to allow resellers to circumvent its ticket limit rules, according to the report.

A settlement is also possible, Bloomberg reported. If the FTC pursues a case and Live Nation loses, the company could face billions of dollars in penalties, as the law permits fines of up to $53,000 per violation.

The scrutiny, which began under former FTC Chair Lina Khan's tenure, gained momentum during the Trump administration and escalated following Taylor Swift's Eras tour ticketing debacle in 2022, according to the report.

The FTC declined to comment, while Live Nation did not immediately respond when contacted by Reuters.

In May, President Donald Trump signed an executive order aimed at protecting fans from "exploitative ticket scalping" and reforming the live entertainment ticketing industry.

Separately, the Justice Department and state attorneys general sued Live Nation and Ticketmaster last year for allegedly monopolizing the live concert industry in ways that hurt artists and fans.

In August, the FTC sued ticket reseller Key Investment Group, accusing it of evading purchase limits to acquire thousands of tickets for events, including Swift's Eras tour, and reselling them at inflated prices.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zoom Video Communications Insider Sold Shares Worth $332,764, According to a Recent SEC Filing
Zoom Video Communications Insider Sold Shares Worth $332,764, According to a Recent SEC Filing
Mar 22, 2024
06:58 AM EDT, 03/22/2024 (MT Newswires) -- Kelly Steckelberg, Chief Financial Officer, on March 20, 2024, sold 5,007 shares in Zoom Video Communications ( ZM ) for $332,764. Following the Form 4 filing with the SEC, Steckelberg has control over a total of 77,235 shares of the company, with 77,235 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1585521/000158552124000050/xslF345X03/wk-form4_1711064830.xml Price: 66.83, Change: +0.29,...
Ukraine's sovereign dollar bonds jump after IMF signs off on $880 mln tranche
Ukraine's sovereign dollar bonds jump after IMF signs off on $880 mln tranche
Mar 22, 2024
By Jorgelina do Rosario LONDON, March 22 (Reuters) - Ukraine's sovereign dollar bonds jump on Friday after the International Monetary Fund signed off on a $880 million tranche of the country's $15.6 billion programme. Adding to the momentum for bonds was an announcement on Thursday that the European Union could use proceeds from frozen Russian assets to help Ukraine within...
EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes
EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes
Mar 22, 2024
March 22 (Reuters) - The European Union's medicines regulator on Friday did not mention Eisai ( ESALF ) and Biogen's Alzheimer's drug in notes and recommendations following a meeting of a committee that reviews the use of drugs in the region. The European Medicines Agency had said it would review the drug, lecanemab, this week. ...
Vodafone-Three Merger Could Lead to 'Higher Prices', 'Reduced Quality' - UK Regulator
Vodafone-Three Merger Could Lead to 'Higher Prices', 'Reduced Quality' - UK Regulator
Mar 22, 2024
06:56 AM EDT, 03/22/2024 (MT Newswires) -- Vodafone's ( VOD ) proposed merger with Three UK could lead to higher prices and reduced quality, Britain's Competition and Markets Authority said Friday. The CMA said it found that Vodafone ( VOD ) and Three provide important alternatives for mobile customers and that combining two of Britain's major mobile network operators would...
Copyright 2023-2026 - www.financetom.com All Rights Reserved